These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8632342)

  • 1. Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.
    Wainscott DB; Lucaites VL; Kursar JD; Baez M; Nelson DL
    J Pharmacol Exp Ther; 1996 Feb; 276(2):720-7. PubMed ID: 8632342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
    Wainscott DB; Cohen ML; Schenck KW; Audia JE; Nissen JS; Baez M; Kursar JD; Lucaites VL; Nelson DL
    Mol Pharmacol; 1993 Mar; 43(3):419-26. PubMed ID: 8450835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
    Kursar JD; Nelson DL; Wainscott DB; Baez M
    Mol Pharmacol; 1994 Aug; 46(2):227-34. PubMed ID: 8078486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog.
    Bonaventure P; Nepomuceno D; Miller K; Chen J; Kuei C; Kamme F; Tran DT; Lovenberg TW; Liu C
    Eur J Pharmacol; 2005 Apr; 513(3):181-92. PubMed ID: 15862800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
    Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives.
    Vangveravong S; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1998 Dec; 41(25):4995-5001. PubMed ID: 9836617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
    Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
    Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
    Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.
    Bonhaus DW; Bach C; DeSouza A; Salazar FH; Matsuoka BD; Zuppan P; Chan HW; Eglen RM
    Br J Pharmacol; 1995 Jun; 115(4):622-8. PubMed ID: 7582481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
    Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.
    Bonhaus DW; Flippin LA; Greenhouse RJ; Jaime S; Rocha C; Dawson M; Van Natta K; Chang LK; Pulido-Rios T; Webber A; Leung E; Eglen RM; Martin GR
    Br J Pharmacol; 1999 Jul; 127(5):1075-82. PubMed ID: 10455251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.
    Audia JE; Evrard DA; Murdoch GR; Droste JJ; Nissen JS; Schenck KW; Fludzinski P; Lucaites VL; Nelson DL; Cohen ML
    J Med Chem; 1996 Jul; 39(14):2773-80. PubMed ID: 8709108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
    Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
    J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.